EU wraps up Sanofi talks aimed at securing coronavirus vaccine
BRUSSELS, July 31 (Reuters) - The European Union's executive on Friday wrapped up talks with French drugmaker Sanofi SASY.PA aimed at securing its COVID-19 vaccine for the 27-country EU bloc.
"The envisaged contract with Sanofi would provide for an option for all EU Member States to purchase the vaccine," the European Commission said in a statement.
"It is envisaged that, once a vaccine has proven to be safe and effective against COVID-19, the Commission would have a contractual framework in place for the purchase of 300 million doses, on behalf of all EU member states."
Sanofi is working on two vaccine projects including one in partnership with GlaxoSmithKline GSK.L.
(Reporting by Foo Yun Chee; Editing by Andrew Cawthorne)
((foo.yunchee@thomsonreuters.com; +32 2 287 6844; Reuters Messaging: foo.yunchee.thomsonreuters.com@reuters.net))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
